In-Vitro Diagnostics Instruments Market By Product Type (Immunochemistry, Clinical microbiology, POCT, SMBG, Tissue Diagnostics, Molecular Diagnostics, Hemostasis) By End-User and Region - Global Forecast to 2026
17 October 2017
find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Data Validation
- Final Projections and Conclusion
The global in-vitro diagnostic instruments market is projected to reach a value of over US$ 13,000 Mn in 2026 at a CAGR of 6.7% over the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global in-vitro diagnostic instruments market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report also offers insightful and detailed information regarding the various key players operating in the global in-vitro diagnostic instruments market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global in-vitro diagnostic instruments market report has been segmented on the basis of type, material, design, application, and region.
An in-vitro diagnostic (IVD) device is defined as a device which is intended for the in-vitro examination of specimens derived from the human body principally to provide information for diagnostic, monitoring or compatibility purposes. These in-vitro diagnostic instruments can be used alone or in combination. In-vitro diagnostics involves tests performed on samples such as blood or tissue that have been collected from the human body. It helps to monitor a person’s overall health check up to help treat or prevent diseases. Devices can range from simple tests to sophisticated DNA technology including reagents, control materials, calibrators, and related instruments.
The Food and Drug Administration (FDA) is involved in regulation of IVD, since the introduction of the Medical Device Amendments of 1976. FDA classifies in-vitro diagnostic instruments into Class I, II, or III, according to level of regulatory control which is necessary to assure safety and effectiveness. The classification of an IVD determines appropriate premarket process. The Code of Federal Regulations lists the classification of existing in-vitro diagnostic instruments in 21 CFR 862, 21 CFR 864, and 21 CFR 866.
Global In-vitro Diagnostic Instruments Market Dynamics:
Increasing personalized healthcare approach and the ease offered by in-vitro diagnostic techniques and devices such as faster detection of asymptomatic infections and diseases and easy patient management at times when clinical presentation is non-specific is driving growth of the global market. In addition, rising adoption of point of-care testing among healthcare professionals as well homecare settings is another factor fueling growth of the target market. Furthermore, the growth of global market is fueled by technological advancements, improved patient monitoring and diagnostic tools, and increased availability of over-the-counter tests. In-vitro diagnostic instruments help to add noteworthy value to diagnosis and prognosis of diseases, thus enhancing well-being of general population.
Report Coverage and Deliverables
In-vitro diagnostics are different from other medical technologies available in the market in many ways, but the most significant difference is that it never comes in direct contact with the patient as they provide information based on analysis of samples.
However, stringent government regulations and lack of reimbursement policies in developing economies is a major factor expected to hamper growth of the global market.
Market Analysis by In-vitro Diagnostic Instruments Product Type:
On the basis of product type, immunochemistry segment is expected to account for major share in terms of revenue in the global market and is projected to register a CAGR of over 7% over the forecast period, owing to launch of new biomarkers by manufacturers and growth in small scale laboratories performing routine tests. In addition, extensive usage of ELISA and semi-quantitative diagnostic tests is another factor supporting growth of the immunochemistry segment in the global market. Moreover, the immunochemistry segment is projected to maintain its dominant revenue contribution in the global market over the forecast period. Furthermore, introduction of new technologies such as immunofluorescence assay and chemiluminescence immunoassay by players in the market also impels growth of the immunochemistry segment.
Increasing healthcare awareness among individuals and rising demand for quality healthcare equipment in medical facilities is supporting the development and launch of innovative products by manufacturers in the global market.
Global In-vitro Diagnostic Instruments Market Analysis by End User:
On the basis of end user, hospitals and diagnostic laboratories segment is expected to account for major share in terms of revenue in the global market and is projected to register a CAGR of over 7% over the forecast period, owing to increasing geriatric population, rising number of patients admitting in hospitals suffering from chronic diseases, and increasing government support for development of hospital infrastructure are major supporting growth of this segment. In addition, rising government funds to facilitate diagnostic laboratories with latest diagnostic equipment and tools is another factor supporting growth of the global market especially in developing countries.
Global Market Analysis by Region:
The Americas market is expected to dominate the global in-vitro diagnostic instruments market in revenue terms, and is estimated to account for largest market revenue share of over 30% in 2017 as compared to that of markets in other regions. It is further expected to maintain its dominant revenue contribution in the global in-vitro diagnostic instruments market over the forecast period. This can be attributed to increasing healthcare awareness among individuals, rising number of chronic cases, availability of technologically advanced diagnostic tests, and adoption of point of-care testing techniques by healthcare professionals. Availability of technologically advanced healthcare infrastructure and novel diagnostic options that help in proper cure and treatment of infections are other factors contributing to the highest market share.
The market in Asia Pacific is projected to register a significant growth of around 7%, which is relatively higher than that of markets in other regions. Increasing patient pool and rising government support for treatment of chronic diseases in countries such as India and China is major expected to support growth of the global market in Asia Pacific market over the forecast period. Product expansion by the key players in the emerging economies is another major factor boosting growth in the Asia Pacific region.
Moreover, markets in Latin America and Middle East & Africa are also projected to witness moderate growth over the forecast period owing to recent advancements in technology, increasing healthcare expenditures, rising initiatives by regulatory bodies and augmented healthcare facilities are expected to boost the target market.
Global in-vitro diagnostic instruments market segmentation by product type:
- Clinical Microbiology
- Tissue Diagnostics
- Molecular Diagnostics
Global in-vitro diagnostic instruments market segmentation by end user:
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
Global in-vitro diagnostic instruments segmentation, by region:
- The Americas
- Asia Pacific
- Rest of the World (ROW)
- Abbott Laboratories
- Roche Diagnostics
- Thermo Fisher Scientific
- Alere Inc.
- Becton Dickinson
- Siemens Healthcare
1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Product
- 2.2.2 Market Snapshot, By End User
- 2.2.3 Market Snapshot, By Region
Don't just take our word. We are trusted by these great companies!